Amterdam Institute for Global health & Development aighd
1
Ana Cecília Gomes Rosa Luiz, Bruna Silveira Caixeta, Milena Ferreira Cruvinel et al.
1
Anaya-Covarrubias, J.Y.
1
and L.Lockerd Maragakis
1
and C. Hoffmann
1
and C. Wonodi
1
and K. Geffert
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Armocida, B.
1
Arrieta, A.
1
ARUP Laboratories
1
Asean Briefing
1
Australian Government Department of Health
1
ÄZQ
1
B. Mason Meier
1
B.S. Kamps
1
BC Centre for Disease Control
1
Beauftragte der Bundesregierung für Migration, Flüchtlinge und Integration
1
Berger, S.
1
Bhopal,S., and M. Nielsen
1
Bigoni, A.
1
BioNTech
1
BMC
1
BMC Health Services
1
Bouley, T. A.
1
Bracho C., Martinez C. et al.
1
Brazilian Journal of Health Review
1
Breathrough Action - For social and behavior change
1
British Medical Association BMA
1
British Medical Journal
1
British Society for Immunology
1
Buliva E., Elnossery S., Okwarah P. et al.
1
Bundesministerium für Migration und Flüchtlinge BAMF
1
C.
1
C. Clift
1
C. Ferreira-Borges
1
C. Victora and M. Chowdury.
1
Camp, R. and C. Hoffmann
1
Care and ONU Femmes
1
Care, ONUu Femmes et al.
1
Carolina L.A. Barbieri, C. Carvalho de Souza Amorim Matos
1
Carrillo-Larco
1
Castillo C., Villalobos Dintrans P. et al
1
Castro, A.
1
Catholic Agency for Overseas Development CAFOD
1
CDA Collaborative Learning Projects
1
Center for Operational Analysis and Research COAR
1
Center for Public Interest Communications, University of Florida
1
Centers for Disease Control and Prevention
1
Cerda A. A., Garcia L. Y.
1
Chairmen of the Committee on Doctrine and the Committee on Pro-Life Activities
1
Children for Health
1
Clinical Drug Information, Inc. and its affiliates and
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Coision Nacional de Seguridad en Vacunas
1
Collective Service RCCE
1
Compass
1
Conlon C., T. McDonnell, M. Barrett, et al.
1
Conseil International des Infirmières
1
Conseil international des Infirmières (CII)
1
Corinne Grainger
1
Corona Tracker
1
Corvalan, C.
1
Couto,M.T.
1
COVID-19 Mental Disorders Collaborators
1
Cristina Aldaz, Francisco Perez
1
D. B. Evans
1
das Neves Martins Pires P.H. , Macaringue C. , Abdirazak A. et al.
1
Desogus, A.
1
Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ)
1
Dheda, K.
1
DHS Program Demographic and Health Surveys
1
Dirección de Control de Enfermedades Inmunoprevenibles
1
Dorcas Aid International
1
Doubova SV, Leslie HH, Kruk ME, et al.
1
Dr. J. Breda
1
Dr. P. Amoth
1
Dr. S. K. Kibias
1
Dressler D. D., MD, MSc Director OF
1
E. Levy Yeyati
1
E. Ross
1
E. Villalobos Prats, A. Sena et al.
1
E. Webb, M. Mckee et al.
1
Eba, B.
1
Education Santé
1
Elsevier Ltd
1
Emanuel, E.J., et al.
1
Emergency Nutrition Network ENN
1
Engelman, D. et al.
1
EQUINET
1
et al
1
Ethiopian Food and Drug Authority
1
Ethiopian Food, Medicine and Healthcare Administration and Control Authority
1
EUAA European Union
1
EuroHealth Observer
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
European AIDS Clinical Society (EACS)
1
European Asylum Support Office
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for disease prevention and Control
1
European Centre for Disease Prevention and Control ECDC
1
European Centre for Disease Prevention and Control (ECDC)
1
European Centre for Disease Prevention and Control ECDC, IOM
1
European Commission's Directorate-General for European Civil Protection and Humanitarian Aid Operations ECHO
1
European Observatory on Health Systems and Policies Eurostation
1
European specialist nurse organisation (ESN)
1
F. Bozzani et al.
1
F. Filippini
1
F. O. Fasina, Fasanmi O.G., Makonnen Y. J., et al.
1
F. Zerbinato Bispo Velasco, de Oliveira Pedroza, G.G. et al.
1
Federal Ministry of Health, Uganda
1
Florida International University
1
Food and Agriculture Organization of the United Nations (FAO)
1
Frase N. S.
1
GAVI Alliance
1
Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO
1
Gavi, the Vaccine Alliance
1
GBD 2019 Human Resources for Health Collaborators
1
GEF
1
German Agency for Quality in Medicine (ÄZQ)
1
Gideon
1
Global Alliance for Vaccines and Immunisation (Gavi)
1
Global Financing Facility (GFF)
1
Global Fund
1
Global Polio Eradication Initiative (GPEI
1
GMDAC, University of Potsdam
1
GOARN
1
Gomes Machado, F.C. et al.
1
Goodman, T.
1
Government of Burundi World Health Organization
1
Government of Malawi
1
Government of the Democratic Republic of the Congo
1
Government of the Republic of Moldova United Nations in Moldova
1
Greinacher, A., et al.
1
Guzman-Vilca, W. C.
1
H. Adler, Gould, S.
1
Haarmann, E.
1
Haider, N.
1
Haldane, V., De Foo, C., Abdalla, S.M. et al.
1
Harding-Zentrum für Risikokompetenz
1
Hategeka C, Carter SE, Chenge FM, et al.
1
Health Care without Harm
1
Health Cluster, Nutrition Cluster, OCHA
1
Health Cluster, WHO
1
Health Sector Syria
1
Healthcare Triage
1
Heinrich-Böll Stiftung, European Union EU
1
Heliyon
1
Hine, P.
1
Hoffmann, C.
1
Holt, E.
1
Holy See Press Office
1
Honein MA, Christie A, Rose DA, et al.
1
Hopkins, D.
1
Hussein Ahmed
1
ICG
1
IFRC - International Federation of Red Cross
1
IHME Institut for Health Metrics and Evaluation
1
ILO
1
iMMAP
1
Immunization Action Coalition
1
Imperial College COVID-19 Response Team
1
Infection Prevention and Control UHL, WHO Headquarters
1
Institut de Médecine Tropicale, Université de Bordeau
1
Institute for research in international assistance
1
Inter-agency Task Force on Financing for Development
1
International Commission of Jurists
1
International Crisis Group
1
International Federation of Red Cross and Red Crescent Societies IFR
1
International Institute for Environment and Developmend (IIED)
1
International Organization for Migration (IOM)
1
International Pharmaceutical Federation (FIP)
1
International Rescue Committee
1
International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health
1
IOM Displacement Tracking Matrix - South Sudan
1
IQ-COVID Bremen
1
J. Bueno de Mesquita
1
J. Ferdosy
1
J. Kates, A. Wexler, et al.
1
J. Tjaden
1
Janković, M.
1
Jara A., Undurraga E. A. et al
1
John Hopkins Bloomberg School
1
John Hopkins University
1
Jurkovič, I.
1
Kelen, G.D.
1
KFF
1
Kim, A.
1
Knoll, M.D.
1
Knowledge Translation Unit
1
Kohler, S.
1
Kompetenznetz Public Health zu COVID-19
1
Kuehn, B.M.
1
Kulkarni, S.
1
Kurowski, C.
1
L. Aparecida de Souza Teles and E.G. da Silva Andrade
1
la DiCEI del Ministerio de Salud de la Nación en conjunto con la Comisión Nacional de Seguridad en Vacunas (CoNaSeVa)
1
Lancet Oncology Commission
1
Leon-Velarde, F.
1
Lewis, C. Jr., Akinyi, M., DeWitte, S. et al.
1
Limaya, R.J.
1
Logothetis, E.
1
Logunov, D.Y, et al.
1
Louka, C.
1
M. A. Babu
1
M. Dara
1
M. M. Ahmmed
1
Machalaba
1
Machalaba, C.
1
Magalhães, C.R.
1
Malawi Human Rights Commission
1
MAMI, Irish Aid, Eleanor Crook Foundation
1
Martinez Viciana, C.
1
Mauder, S., K. Geffert
1
MEDBOX- The Aid libary
1
Medical Aid Films
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
Migration Policy Institute
1
Ministerio da Saude do Brasil
1
Ministerio de Salud Chile
1
Ministerio de Salud El Salvador
1
Ministerio de Salud Pública del Ecuador
1
Ministerio de Salud y Proteccion Social Bogota, Colombia
1
Ministerio de Salud, Colombia
1
Ministerio de Salud, Bogota, Colombia
1
Ministero della Salute
1
Ministère de la Santé, DR Congo
1
Ministério da Saúde Brasil
1
Ministério da Saúde, Brasil
1
Ministry of Health
1
Ministry of Health & Family Welfare ,India
1
Ministry of Health & Family Welfare, Goverment of India
1
Ministry of Health and Family Welfare, India
1
Ministry of Health Ghana
1
Ministry of Health Rwanda, The DHS Program, et al.
1
Ministry of Health Uganda
1
Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC)
1
Ministry of Health, South Africa
1
Misereor, Brot für die Welt, Global Policy Forum GPF
1
Mixed Migration Centre
1
Morbidity and Mortality Weekly Report MMWR
1
Msomi, N.
1
Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)
1
N.Paul, T. Bärnighausen, P. Geldsetzer
1
National Academies of Sciences, Engineering, and Medicine
1
National Department of Health (NDoH) South Africa
1
National Department of Health South Africa
1
National Department of Health South-Africa
1
National Libary of Medicine
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with ...the Global Polio Eradication Initiative (GPEI) commitment to support the COVID-19 pandemic response.
It highlights the decision making framework to guide the level of polio surveillance activities at country level including; the measures to put in place to ensure a minimum level of polio surveillance in the field and in the laboratory, and the trigger to return to normal polio function.more
The virtual conference, co-organised by the Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC) brought together African leaders, public health professionals and researchers, policymakers, business leaders and civil society and commun...ity leaders.
The objective was to discuss strategies and approaches to remove barriers to widespread delivery and uptake of effective COVID-19 vaccines across Africa, guided by African voices and indigenous values. The goal of the conference was to provide input for a framework for fair, equitable and timely allocation of COVID-19 vaccines in Africa.more
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...nd Melinda Gates Foundation and the Mastercard Foundation. These partners have helped to shape and drive the continent’s strategic response to the COVID-19 pandemic and have offered support to ensure the continent receives a fair and equitable share of the COVID-19 vaccine without delay.
We look forward to continuing and deepening our partnership for the benefit of the public health of Africa.more
Vaccines (shots) are one of the tools we have to fight the COVID-19 pandemic. Vaccines work with your body’s natural defenses so your body will be ready to fight the virus.
Alternative Languages: Arabic | Spanish | Korean | Russian | Simplified Chinese | Tagalog | Traditional Chinese | Vietnamese...
https://www.cdc.gov/coronavirus/2019-ncov/communication/print-resources.html?Sort=Date%3A%3Adescmore
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being halted.
It says the number of children being tr...eated for severe malnutrition fell by more than 80% in Bangladesh and Nepal, and immunisation among children dropped by 35% and 65% in India and Pakistan respectively...
It also estimates that there have been some 3.5 million additional unwanted pregnancies, including 400,000 among teenagers, due to poor or no access to contraception...
The interruption to health services also affected those suffering from other diseases - the report predicts an additional 5,943 deaths across the region among adolescents who couldn't get treated for tuberculosis, malaria, typhoid and HIV/Aids.more
La OPS, dentro de su empeño constante por apoyar a los países de las Américas, publica el presente documento con ánimo de facilitar la elaboración de una estrategia de comunicación de riesgos y participación comunitaria para la vacunación contra la COVID-19. Su finalidad es contribuir a fort...alecer las capacidades y la planificación de la comunicación de los ministerios o secretarías de salud, así como de otros organismos encargados de comunicar en el área de las nuevas vacunas contra la COVID-19 en las Américas.
Available in English, Spanish and Portuguesemore
A Organização Pan-Americana da Saúde, em seu esforço constante e permanente para apoiar os países das Américas, apresenta este documento para facilitar a formulação de uma estratégia de comunicação de riscos e participação comunitária (CRPC) para a vacinação contra o SARS-CoV-2. O in...tuito é contribuir para o fortalecimento das capacidades de comunicação e planejamento dos ministérios e secretarias de saúde, bem como de outros órgãos responsáveis pela comunicação na área das novas vacinas contra a COVID-19 nas Américas.
Available in English, Spanish and Portuguesemore
Les vaccins sont conçus pour vous conférer une immunité sans les dangers d’avoir contracté la maladie. Il est courant de ressentir quelques effets indésirables légers à modérés après avoir reçu un vaccin. Ils sont dus au fait que votre système immunitaire demande à votre organisme d'a...ugmenter le flux sanguin afin que davantage de cellules immunitaires puissent circuler, et il élève votre température interne afin de tuer le virus. Les vaccins nous aident à nous protéger contre les maladies, et ressentir des effets indésirables légers ou modérés après avoir reçu un vaccin est un signe que ce vaccin et notre système immunitaire fonctionnent.more
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...й лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)
(Grundimmunisierung und Auffrischimpfungen) – mit Vektor-Impfstoff – (COVID-19 Vaccine Janssen® von Janssen Cilag International/Johnson & Johnson)
Stand: 14. Februar 2022 (dieses Aufklärungsmerkblatt wird laufend aktualisiert)more
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...asintomáticos probablemente sea más elevada.more
Este informe presenta los resultados obtenidos de la evaluación de la efectividad de las vacunas contra la COVID-19 en Chile utilizando la red de vigilancia centinela de infecciones respiratorias agudas graves (IRAG). Los resultados que se presentan en este informe provienen de los datos proporcion...ados por esta red para el periodo de enero a diciembre de 2021.more
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan... Nacional de Vacunación contra COVID-19 en Paraguaymore
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de... salud se beneficiaría considerando el mayor riesgo de exposición y la caída de la respuesta inmune con el tiempo. En base a lo señalado previamente se recomienda incorporar y
priorizar un segundo refuerzo al esquema de vacunación contra la COVID-19 del:
- Personal de salud independientemente de la edad
- Personas de 50 años o mayores
- Personas de 12 años o más con inmunocompromiso
A la vez, se progresará de manera escalonada y simultánea con la vacunación de segundo refuerzo del:
- Personal estratégico
- Personas de 18 a 49 años con factores de riesgo
Continuando en la estrategia de segundo refuerzo todas las personas a partir de los 18 años. Las personas gestantes con indicación de segundo refuerzo, se recomienda vacunas de plataforma de ARNm (Pfizer-BioNTech o Moderna)more
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...a evaluado la eficacia).Entre los participantes sin evidencia de infección previa por SARS-CoV-2, hubo 3 casos de COVID-19 entre los 1.305 receptores de vacuna a partir de los 7 días de la segunda dosis y 16 entre los 663 receptores de placebo.more